Among these transcripts, MEG3 has emerged as one of the most consistent tumor suppressors, with numerous studies associating its downregulation with poor prognosis and aggressive behavior in different malignancies, including ovarian carcinoma (Seyed Hosseini et al., 2019). This evidence concerns the gene MEG3 and ovarian carcinoma.